<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03621748</url>
  </required_header>
  <id_info>
    <org_study_id>18-005248</org_study_id>
    <nct_id>NCT03621748</nct_id>
  </id_info>
  <brief_title>Awake vs. Asleep Craniotomy for Non-eloquent Gliomas</brief_title>
  <official_title>Randomized Control Trial for Awake vs. Asleep Craniotomy for Non-eloquent Gliomas</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mayo Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mayo Clinic</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study protocol examines a comparison between local and general anesthesia (Awake vs.
      Asleep Craniotomy) in the removal of brain tumors that are in areas of the brain that do not
      directly control bodily functions (non-eloquent gliomas).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a single-center, prospective randomized open or non-blinded end-point (PROBE)
      clinical trial. Patients will be selected by the neurosurgeon according to the inclusion and
      exclusion criteria. Patients who consent to randomization will have confirmed non-eloquent
      status confirmed by independent surgeon and will be randomized into 1 of 2 treatment groups
      utilizing a dynamic minimization approach. The experimental group with randomization of
      patients who will undergo awake craniotomy for both high and low grade gliomas in
      non-eloquent areas or a control group of patients who will have asleep craniotomy for both
      high and low grade gliomas in non-eloquent regions.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 1, 2019</start_date>
  <completion_date type="Anticipated">December 2020</completion_date>
  <primary_completion_date type="Anticipated">June 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Extent of resection</measure>
    <time_frame>up to 48 hrs post operation</time_frame>
    <description>Extent of resection (EOR) defined as the residual volume, in cm3, of tumor measured by MRI</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Percentage of baseline tumor volume resected</measure>
    <time_frame>up to 48 hrs post operation</time_frame>
    <description>Measured by MRI</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>VAS Postoperative anxiety</measure>
    <time_frame>Day 1(+14 days) , Post op day 0, 1, 2 weeks, 3mth</time_frame>
    <description>Postoperative Anxiety scale measured using a 0 to 10 visual analog scale (0: no anxiety, 10: worst anxiety)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of Surgery</measure>
    <time_frame>Intraoperative</time_frame>
    <description>defined as time entering OR and leaving OR</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Length of hospital stay (LOS)</measure>
    <time_frame>0-30 days post operation</time_frame>
    <description>admission to discharge</description>
  </other_outcome>
  <other_outcome>
    <measure>The Karnofsky Performance Score</measure>
    <time_frame>Day 1 (+14 days), Post-operative up to 48 hrs, 3-6 weeks, 3mths, 6mths, and 9 mths</time_frame>
    <description>(KPS) ranking runs from 100 to 0, where 100 is &quot;perfect&quot; health and 0 is death</description>
  </other_outcome>
  <other_outcome>
    <measure>FACT-Br</measure>
    <time_frame>Day 1 (+14 days), Post-operative up to 48 hrs, 3-6 weeks, 3mths, 6mths, and 9 mths</time_frame>
    <description>The FACT-Brain (FACT-Br) provides an additional set of disease-specific questions pertaining to brain neoplasms</description>
  </other_outcome>
  <other_outcome>
    <measure>Post-operative pain scale</measure>
    <time_frame>Day 1 (+14 days), Post-operative up to 48 hrs, 3-6 weeks, 3mths, 6mths, and 9 mths</time_frame>
    <description>0 to 10 (0: No pain, 10: Worst pain) - Numeric Scale</description>
  </other_outcome>
  <other_outcome>
    <measure>Cost of treatment</measure>
    <time_frame>captured until 30 days post operation</time_frame>
    <description>Analysis to include standardized cost, physician service cost, cost of hospitalization and 30 days post-hospitalization cost</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Intracranial Glioma</condition>
  <arm_group>
    <arm_group_label>Non-Awake Cohort</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Cohort undergoing craniotomy utilizing general anesthesia protocol</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Awake Cohort</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Cohort undergoing craniotomy utilizing awake anesthesia protocol</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Awake Anesthesia Protocol</intervention_name>
    <description>Awake is defined as the patient being awake with electrical brain stimulation mapping during the critical portions of the procedure.</description>
    <arm_group_label>Awake Cohort</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Non-awake Anesthesia Protocol</intervention_name>
    <description>Non-awake is general anesthesia as per convention with intubation.</description>
    <arm_group_label>Non-Awake Cohort</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        INCLUSION CRITERIA

          1. Patients with age â‰¥18 years old.

          2. WHO grade I, II, III, and IV Glioma in non-eloquent brain cortex based on magnetic
             resonance imaging (MRI)

          3. An elective procedure.

          4. A single lesion.

          5. No major comorbidities that would necessitate an extended hospital stay.

          6. Newly diagnosed tumors.

        EXCLUSION CRITERIA

          1. Patients with age &lt; 18 years old.

          2. Non-gliomas

          3. Eloquent location (motor, sensory, language)

          4. Non-elective procedure.

          5. Multiple lesions.

          6. Major comorbidities.

          7. Recurrent tumors.

          8. Patients lacking capacity to consent.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kaisorn L Chaichana</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mayo Clinic</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Mayo Clinic in Florida</name>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <zip>32224</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Elizabeth Martin</last_name>
      <phone>904-953-3844</phone>
      <email>Martin.Elizabeth1@mayo.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>https://www.mayo.edu/research/clinical-trials</url>
    <description>Mayo Clinic Clinical Trials</description>
  </link>
  <verification_date>August 2019</verification_date>
  <study_first_submitted>August 2, 2018</study_first_submitted>
  <study_first_submitted_qc>August 6, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 8, 2018</study_first_posted>
  <last_update_submitted>August 14, 2019</last_update_submitted>
  <last_update_submitted_qc>August 14, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">August 16, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mayo Clinic</investigator_affiliation>
    <investigator_full_name>Kaisorn L. Chaichana</investigator_full_name>
    <investigator_title>Senior Associate Consultant</investigator_title>
  </responsible_party>
  <keyword>craniotomy</keyword>
  <keyword>awake craniotomy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Glioma</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

